Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (DE:3U2)
FRANKFURT:3U2
Dr. Martens Plc (3U2) Stock Price & Analysis
2 Followers
3U2 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.73 - €1.88
Previous Close€0.8
Volume0.00
Average Volume (3M)1.51K
Market Cap
€828.71M
Enterprise Value€1.16B
Total Cash (Recent Filing)£157.50M
Total Debt (Recent Filing)£445.80M
Price to Earnings (P/E)N/A
Beta1.83
Next Earnings
May 30, 2024EPS Estimate
€0.06Last Dividend Ex-Date
Jan 04, 2024Dividend Yield7.89%
Share Statistics
EPS (TTM)N/A
Shares Outstanding969,681,372
10 Day Avg. Volume0
30 Day Avg. Volume1,513
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)2.58
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.82Price Target Upside-1.33% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Dr. Martens Plc News
PremiumGlobal Markets
Dr. Martens Share Price Plunges on Profit Warning
Bulls Say, Bears Say
Bulls Say
Company OutlookThe company reiterated its forward outlook for FY24, signaling confidence in its future performance.
LeadershipDr. Martens enhances its executive team by appointing Ije Nwokorie, a former Senior Director of Apple Retail, as Chief Brand Officer, strengthening the company's brand and retail strategy.
Product StrategyThe Direct-to-Consumer rollout, coupled with pricing and space expansion, is poised to drive retail growth.
Bears Say
Earnings DowngradeDr. Martens reported soft 3Q24 revenue with a cFX revenue decline of 18%, leading to a lowered FY24 guidance.
Market SentimentAnalyst has cut the price target to 110p, reflecting a reduced valuation of the company's stock amidst unfavourably warm weather delaying the boot season and affecting sales.
Operational ChallengesSignificant destocking across US wholesale channel has negatively impacted revenues and brought attention to inventory levels as a concern for future cash conversion.
---
3U2 FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest stock price was €0.73 and its highest was €1.88 in the past 12 months.
What is Dr. Martens Plc’s market cap?
Currently, no data Available
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is May 30, 2024 which is in 34 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 30, 2023. The company reported €0.022 earnings per share for the quarter, the consensus estimate of €0.022 by €0.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Overvalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Annually dividend of €0.02 which represents an annual dividend yield of 7.89%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is €0.06.
How many shares outstanding does Dr. Martens Plc have?
Currently, no data Available
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of €0.022 in its last earnings report, expectations of €0.022. Following the earnings report the stock price went down -20.126%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in DE:3U2
---
Dr. Martens Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
€0.82 (-1.33% Downside)
€0.82 (-1.33% Downside)
Blogger Sentiment
Bullish
DE:3U2 Sentiment 100%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.51%
12-Months-Change
Fundamentals
Return on Equity
29.07%
Trailing 12-Months
Asset Growth
4.80%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories.
---
3U2 Stock 12 Months Forecast
Average Price Target
€0.82
▼(-1.33% Downside)
Technical Analysis
Best Analysts Covering 3U2
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-21.70%
reiterated a sell rating 10 days ago
Copying Louise Singlehurst's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -21.70% per trade.
---